BICAVERA

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Poland

Active ingredients

The drug BICAVERA contains a combination of these active pharmaceutical ingredients (APIs):

1 Calcium chloride
UNII M4I0D6VV5M - CALCIUM CHLORIDE

Calcium is the most abundant mineral in the body, and is an essential body electrolyte. Homeostasis is mainly regulated by the parathyroid hormone, by calcitonin, and by the activated form of vitamin D. Calcium is a structural component of bones and teeth. It is also required for blood clotting, neurotransmitter release, muscle contraction and normal heartbeat.

Read about Calcium chloride
2 Glucose monohydrate
UNII LX22YL083G - DEXTROSE MONOHYDRATE

Glucose is frequently used in both adults and children to restore blood glucose concentrations in the treatment of hypoglycaemia resulting from insulin excess or from other causes. The metabolism of glucose is an energy source for the body.

Read about Glucose
3 Magnesium chloride
UNII 02F3473H9O - MAGNESIUM CHLORIDE
Read about Magnesium chloride
4 Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.

Read about Sodium chloride
5 Sodium hydrogen carbonate
UNII 8MDF5V39QO - SODIUM BICARBONATE

Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide.

Read about Sodium bicarbonate

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
BICAVERA Solution for peritoneal dialysis Marketing Authorisation Holder MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B05DB Hypertonic solutions B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05D Peritoneal dialytics
Discover more medicines within B05DB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1146316, 1146327, 1779509, 1855694, 1855706
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 64754, 64755, 64756, 81963, 81964, 81965
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 062849, 179126, 180171, 185031, 197200, 373708, 374441, 375130, 413919, 418746, 420664, 444276, 447561, 451990, 459089, 522440, 526406, 589414
Country: FR Base de données publique des médicaments Identifier(s): 61158552, 65919752, 68225352, 69158682
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100339669, 100339675, 100339681

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.